Registration number: 09662476

Washington Eyecare Limited

Contents

Balance Sheet	1 to 2
Statement of Changes in Equity	3
Notes to the Unaudited Financial Statements	4 to 8

Washington Eyecare Limited

(Registration number: 09662476)
Balance Sheet as at 31 December 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	5	14,800	30,007
Current assets
Stocks	6	32,030	30,798
Debtors	7	26,703	17,298
Cash at bank and in hand		189,273	224,227
		248,006	272,323
Creditors: Amounts falling due within one year	8	(90,063)	(149,210)
Net current assets		157,943	123,113
Total assets less current liabilities		172,743	153,120
Creditors: Amounts falling due after more than one year	8	(160,018)	(152,013)
Provisions for liabilities		(3,700)	-
Net assets		9,025	1,107
Capital and reserves
Called up share capital		50	50
Capital redemption reserve		(40)	(40)
Retained earnings		9,015	1,097
Shareholders' funds		9,025	1,107

Washington Eyecare Limited

(Registration number: 09662476)
Balance Sheet as at 31 December 2025

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 23 July 2026
 

......................................... Mr D Quinn Director

Washington Eyecare Limited

Statement of Changes in Equity for the Year Ended 31 December 2025

	Share capital £	Capital redemption reserve £	Retained earnings £	Total £
At 1 January 2025	50	(40)	1,097	1,107
Profit for the year	-	-	76,918	76,918
Dividends	-	-	(69,000)	(69,000)
At 31 December 2025	50	(40)	9,015	9,025

	Share capital £	Capital redemption reserve £	Retained earnings £	Total £
At 1 January 2024	60	-	4,607	4,667
Profit for the year	-	-	104,440	104,440
Other comprehensive income	-	-	50	50
Total comprehensive income	-	-	104,490	104,490
Dividends	-	-	(53,000)	(53,000)
Purchase of own share capital	(10)	-	(55,000)	(55,010)
Other capital redemption reserve movements	-	(40)	-	(40)
At 31 December 2024	50	(40)	1,097	1,107

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Washington Eyecare Limited
Unit 77 Albany Mall
The Galleries
Washington
Tyne & Wear
NE38 7SD

These financial statements were authorised for issue by the director on 23 July 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures and fittings	20% Straight line
Office equipment	20% Straight line
Plant and machinery	33% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	10% Straight line

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 8 (2024 - 8).

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

4	Intangible assets

	Franchise £	Total £
Cost or valuation
At 1 January 2025	5,000	5,000
At 31 December 2025	5,000	5,000
Amortisation
At 1 January 2025	5,000	5,000
At 31 December 2025	5,000	5,000
Carrying amount
At 31 December 2025	-	-

5	Tangible assets

	Furniture, fittings and equipment  £	Computer equipment £	Total £
Cost or valuation
At 1 January 2025	347,483	22,130	369,613
Additions	4,118	2,593	6,711
At 31 December 2025	351,601	24,723	376,324
Depreciation
At 1 January 2025	321,132	18,474	339,606
Charge for the year	17,607	4,311	21,918
At 31 December 2025	338,739	22,785	361,524
Carrying amount
At 31 December 2025	12,862	1,938	14,800
At 31 December 2024	26,351	3,656	30,007

6

Stocks

	2025 £	2024 £
Finished goods and goods for resale	32,030	30,798

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

7

Debtors

Current	Note	2025 £	2024 £
Trade debtors		18,404	8,693
Amounts owed by related parties		672	672
Prepayments		7,627	7,819
Other debtors		-	114
		26,703	17,298

8

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings		10,428	39,001
Trade creditors		38,402	45,446
Taxation and social security		35,971	43,435
Accruals and deferred income		4,017	18,549
Other creditors		1,245	2,779
		90,063	149,210

There are two charges over the company at the year end date. The first from National Westminster Bank PLC was delivered 2nd February 2016 and is a fixed charge. The second again from National Westminster Bank PLC was delivered 29th February 2016 and is a fixed charge.

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £10,428 (2024 - £39,001).

Creditors: amounts falling due after more than one year

	Note	2025 £	2024 £
Due after one year
Loans and borrowings		160,018	152,013

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £160,018 (2024 - £152,013).